🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Aster DM Quality Care Limited ASTERDM NIFTY_SMALLNSEPHARMA

Healthcare · Medical Care Facilities · India
https://www.asterhospitals.in
Company Profile ↓
₹814.00
+36.51% 1Y
Mkt Cap₹42,175.05 Cr
P/E7.55
P/B9.18
Div. Yield0.49%
52W High₹814.95
52W Low₹535.60
Book Value₹88.32
EPS (TTM)₹107.85

Company Overview

Aster DM Quality Care Limited operates as an integrated healthcare provider in India. The company operates through four healthcare brands including Aster DM, CARE Hospitals, Evercare, and KIMSHEALTH. It offers comprehensive healthcare services including primary, secondary, tertiary and quaternary care across key areas including oncology, cardiac sciences, neurosciences, gastro sciences, orthopedics, nephrology, organ transplantation, mother and childcare, and critical care. In addition, the company operates retail pharmacies and optical outlets. Aster DM Quality Care Limited was formerly known as Aster DM Healthcare Limited and changed its name to Aster DM Quality Care Limited in July 2026. The company was founded in 1987 and is based in Bengaluru, India.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 16.3% CAGR over the past five years.

Reasonable Valuation

Trades at a P/E of 7.5, below the sector median of 39.7.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹4,643.22 Cr (+12.2% YoY); net profit ₹388.14 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +12.2%, earnings -92.8%.
  • 5-Year Trend Long-term compounding — revenue CAGR 16.3%, profit CAGR -3.0%.

Growth & Price Performance

Compounded Sales Growth

5 Years:16.30%
1 Year:12.20%

Compounded Profit Growth

5 Years:-2.97%
1 Year:-92.78%

Stock Price Performance

1 Year:+36.51%
6 Months:+33.05%
3 Months:+20.71%
1 Month:+3.47%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 100% of range
₹535.60 ₹814.95
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)62.52 · Neutral
Price Performance
1M+3.47%
3M+20.71%
6M+33.05%
1Y+36.51%
Valuation vs Sector

P/E of 7.55 is below the sector median of 39.70 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 16.3% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Earnings shrank at -3.0% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
7.55
Industry PE
39.70
Forward P/E
43.74
PEG Ratio
-
Book Value
₹88.32
Price to Book
9.18
P/S
9.07
EV/EBITDA
47.88
Dividend Yield
0.49%

Growth (CAGR)

Revenue 5Y
16.30%
Profit 5Y
-2.97%
Revenue (YoY)
12.20%
Earnings (YoY)
-92.78%

Profitability & Returns

ROCE
9.71%
ROE
8.48%
ROA
4.78%
Profit Margin
8.36%
Op Margin
13.71%
Gross Margin
77.41%
EPS (Latest Qtr)
₹2.71
EPS (TTM)
₹107.85

Balance Sheet & Liquidity

Debt/Equity
0.49
Quick Ratio
1.90
Current Ratio
1.99
Debt
₹2,219.66 Cr
Total Assets
₹8,111.96 Cr
Current Assets
₹1,947.79 Cr
Working Capital
₹968.63 Cr

Ownership

Promoter Holding
53.34%
Chg in Prom Hold
-0.00%
FII / Inst Holding
34.25%
Chg in FII Hold
-0.01%

Financial Snapshot

Enterprise Value
₹42,175.05 Cr
Total Revenue (TTM)
₹4,643.22 Cr
EBITDA
₹956.92 Cr
Free Cash Flow
₹178.40 Cr
Operating Cash Flow
₹655.92 Cr
Shares Outstanding
₹51.81 Cr
Gross Margin
77.41%
Payout Ratio
53.19%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 ASTERDM Aster DM Quality Care Limited NIFTY_SMALLNSEPHARMA 814.00 7.55 ₹42,175.05 Cr 0.49% 9.71% 8.48% 16.30% -2.97%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,948.80 40.77 ₹4.68 L Cr 0.83% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 7,315.50 75.61 ₹1.94 L Cr 0.44% 18.96% 15.32% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,952.20 87.70 ₹1.68 L Cr 0.78% 9.05% 25.79% 13.27% 20.22%
5 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,981.00 66.51 ₹1.29 L Cr 0.23% 19.79% 20.48% 15.33% 33.34%
6 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,440.10 22.07 ₹1.16 L Cr 0.90% 14.86% 11.27% 7.23% 11.45%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,137.40 22.71 ₹1.14 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,494.30 21.42 ₹1.14 L Cr 0.72% 28.42% 23.76% 19.10% 131.46%
9 MAXHEALTH Max Healthcare Institute Limited NSEAIPHARMA 1,099.00 99.82 ₹1.07 L Cr 0.18% 12.57% 13.42% 22.37% 9.34%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 807.00 Cr841.00 Cr929.00 Cr955.00 Cr974.00 Cr1,002.00 Cr1,086.44 Cr1,049.81 Cr1,000.34 Cr1,077.87 Cr1,197.00 Cr1,185.76 Cr1,182.38 Cr
Cost of Revenue ------237.48 Cr247.01 Cr225.23 Cr247.14 Cr-267.48 Cr263.16 Cr
Gross Profit ------848.96 Cr802.80 Cr775.11 Cr830.73 Cr-918.28 Cr919.22 Cr
Operating Expenses 687.00 Cr722.00 Cr787.00 Cr805.00 Cr817.00 Cr841.00 Cr691.49 Cr675.83 Cr646.99 Cr686.59 Cr961.00 Cr774.70 Cr753.88 Cr
Operating Income 66.00 Cr68.00 Cr88.00 Cr92.00 Cr98.00 Cr101.00 Cr157.47 Cr126.97 Cr128.12 Cr144.14 Cr170.00 Cr143.58 Cr165.34 Cr
EBITDA 120.00 Cr119.00 Cr142.00 Cr149.00 Cr156.00 Cr161.00 Cr252.38 Cr194.86 Cr186.92 Cr230.43 Cr236.00 Cr202.18 Cr260.58 Cr
Interest Expense 25.00 Cr25.00 Cr30.00 Cr25.00 Cr30.00 Cr29.00 Cr31.46 Cr30.77 Cr32.43 Cr30.77 Cr31.00 Cr31.46 Cr29.99 Cr
Pretax Income 190.00 Cr26.00 Cr-7.00 Cr220.00 Cr28.00 Cr5,191.00 Cr158.65 Cr101.88 Cr90.54 Cr136.44 Cr167.00 Cr103.05 Cr163.35 Cr
Tax Provision 7.60 Cr6.24 Cr-8.40 Cr11.00 Cr30.24 Cr51.91 Cr52.89 Cr37.49 Cr5.00 Cr42.88 Cr45.09 Cr44.40 Cr9.77 Cr
Net Income 183.00 Cr20.00 Cr-15.00 Cr209.00 Cr-2.00 Cr5,152.00 Cr96.84 Cr56.79 Cr79.02 Cr85.52 Cr121.00 Cr52.45 Cr140.17 Cr
Diluted EPS 3.420.10-0.623.59-0.48103.001.941.141.581.672.121.022.71

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 3,876.00 Cr5,250.00 Cr5,931.00 Cr6,721.00 Cr7,963.00 Cr8,652.00 Cr8,608.00 Cr-2,951.80 Cr3,638.19 Cr4,138.46 Cr4,643.22 Cr
Cost of Revenue --------784.12 Cr915.92 Cr938.33 Cr1,048.79 Cr
Gross Profit --------2,167.68 Cr2,722.27 Cr3,200.13 Cr3,594.43 Cr
Operating Expenses 3,370.00 Cr4,805.00 Cr5,582.00 Cr6,089.00 Cr6,886.00 Cr7,187.00 Cr7,506.00 Cr-1,901.93 Cr2,355.29 Cr2,684.44 Cr2,957.65 Cr
Operating Income 362.00 Cr202.00 Cr27.00 Cr334.00 Cr771.00 Cr879.00 Cr485.00 Cr-265.75 Cr366.98 Cr515.69 Cr636.78 Cr
EBITDA 506.00 Cr445.00 Cr349.00 Cr632.00 Cr1,077.00 Cr1,465.00 Cr1,103.00 Cr-1,061.05 Cr1,355.03 Cr849.55 Cr956.92 Cr
Interest Expense 79.00 Cr189.00 Cr371.00 Cr204.00 Cr205.00 Cr391.00 Cr334.00 Cr-85.15 Cr106.09 Cr123.81 Cr122.98 Cr
Pretax Income 306.00 Cr38.00 Cr108.00 Cr308.00 Cr410.00 Cr330.00 Cr205.00 Cr-195.46 Cr261.19 Cr471.06 Cr569.69 Cr
Tax Provision 33.66 Cr29.64 Cr10.80 Cr24.64 Cr41.00 Cr16.50 Cr26.65 Cr-35.87 Cr56.51 Cr134.37 Cr142.59 Cr
Net Income 272.00 Cr8.00 Cr98.00 Cr282.00 Cr367.00 Cr315.00 Cr178.00 Cr-424.91 Cr129.28 Cr5,377.83 Cr388.14 Cr
Diluted EPS 7.000.202.525.326.595.542.9610.578.532.60107.85-

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 4,409.00 Cr5,743.00 Cr6,804.00 Cr7,479.00 Cr8,928.00 Cr12,405.00 Cr11,620.00 Cr-14,881.20 Cr17,991.31 Cr6,606.38 Cr8,111.96 Cr
Current Assets --------4,921.56 Cr14,165.30 Cr1,901.47 Cr1,947.79 Cr
Cash & Equivalents --------378.53 Cr82.23 Cr164.59 Cr228.07 Cr
Inventory --------1,305.62 Cr110.52 Cr92.35 Cr91.16 Cr
Receivables --------2,336.31 Cr233.35 Cr257.81 Cr307.23 Cr
Total Liabilities --------10,020.74 Cr12,961.20 Cr2,954.93 Cr3,278.26 Cr
Current Liabilities --------4,655.28 Cr11,288.26 Cr879.21 Cr979.16 Cr
Long Term Debt --------1,312.30 Cr446.08 Cr483.71 Cr558.44 Cr
Total Debt 1,091.00 Cr3,321.00 Cr2,758.00 Cr2,352.00 Cr2,788.00 Cr5,605.00 Cr4,804.00 Cr-5,700.30 Cr1,383.75 Cr2,017.77 Cr2,219.66 Cr
Total Equity 1,485.00 Cr420.00 Cr1,875.00 Cr2,832.00 Cr3,214.00 Cr3,272.00 Cr3,372.00 Cr-4,448.07 Cr4,559.79 Cr3,428.07 Cr4,575.86 Cr
Shares Outstanding --------49.95 Cr49.95 Cr49.95 Cr51.81 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 236.00 Cr203.00 Cr361.00 Cr537.00 Cr601.00 Cr1,223.00 Cr1,569.00 Cr-1,833.98 Cr157.81 Cr425.05 Cr655.92 Cr
Investing Cash Flow -439.00 Cr-775.00 Cr-1,136.00 Cr-522.00 Cr-702.00 Cr-658.00 Cr-333.00 Cr--971.88 Cr-884.65 Cr6,014.87 Cr-288.21 Cr
Financing Cash Flow 203.00 Cr578.00 Cr654.00 Cr46.00 Cr134.00 Cr-675.00 Cr-1,116.00 Cr--817.39 Cr1,052.83 Cr-6,357.81 Cr-304.34 Cr
Capital Expenditure -412.00 Cr-739.00 Cr-926.00 Cr-514.00 Cr-537.00 Cr-508.00 Cr-386.00 Cr--847.88 Cr-805.58 Cr-356.73 Cr-477.52 Cr
Free Cash Flow -176.00 Cr-536.00 Cr-565.00 Cr23.00 Cr64.00 Cr715.00 Cr1,183.00 Cr-986.10 Cr-647.77 Cr68.32 Cr178.40 Cr
Net Change in Cash -1.00 Cr5.00 Cr-122.00 Cr61.00 Cr33.00 Cr-110.00 Cr120.00 Cr-44.71 Cr325.99 Cr82.11 Cr63.37 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % --------73.4%74.8%77.3%77.4%
Operating Margin % 9.3%3.8%0.5%5.0%9.7%10.2%5.6%-9.0%10.1%12.5%13.7%
Net Margin % 7.0%0.2%1.7%4.2%4.6%3.6%2.1%-14.4%3.6%129.9%8.4%
ROE % 18.3%1.9%5.2%10.0%11.4%9.6%5.3%-9.6%2.8%156.9%8.5%
ROCE % --------2.6%5.5%9.0%8.9%

Shareholding Pattern

Insiders
53.34%
Institutions
34.25%
Public Float
73.39%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ASTERDM

Google News hu, 21 May 2026

How The Aster DM Healthcare (NSEI:ASTERDM) Narrative Is Shifting With New Valuation Assumptions - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQd2dWVVVERU9rbndLeG9oOUVzVjR3aHlvSnJKMmo3VkhyWENZaWdZYUF2SGt3blNtbWJYcDR5aXMxa1F2RTRaajZGS2NNdUpiWlZqUzFIc1RObHhxQVc3UmdqeGY0akpDaVAzMWN0WEVCU2hWTERyaUZXbWJiQjg0VUpPUDJ4SVB3R2cwZn…

Google News Fri, 26 Jun 2026

ASTERDM Forecast — Price Target — Prediction for 2027 - TradingView

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTFBXU3FETXdnSENjUFZmVHdyQUpQdmo0TlFGS3dmaHN4cWlhZmkzRjNuTm10dnJZMmo1QTFHdFF0aTh0ejlzLWh3aDR3UjBoNjE4TktfTG8xYUluandUX0FlYk9BbWlnNjJnbWNlUHhSWG1icHZBLS14LXVn?oc=5" target="_blank">AST…

Google News Fri, 23 Jan 2026

Arms Maker CSG’s Shares Surge on Amsterdam Stock-Market Debut - WSJ

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNMTd1cjQyRks5ZjlOdGNDRUNpV2l6XzAxbXh1bjJmZ3B0VkVKdEROa0JpRm5VbmJrT0VoZVhkMG5YV3JLVTBFNzN0NXNiYWoxaEd1OUVrRTBrZlJXYlNxaW10dFhCVnBwbU10YXFoemR5Z2NUcEh2TlktMFVIYXpldWE3UjZqeXZNbkR3bW…

Google News ue, 14 Apr 2026

Amsterdam court rejects Italy's CDP bid to block CEO reappointment at Milan bourse - Reuters

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxORVZFNFJEMGQ0Y3l2NXBaQ1dnQTBxNXFsR0d6MndlTjZDZENvX3ZBRGtWS2l3RTBPNnQtajRBQVhXLXlIai1IS1cxWkg2WS1SejVQQ1ZIT0RwTmF0ZXp3Sm5GUU5jUlV6NHBudzNXMFJzc0ZiQmx4QjItLWdpNjJmUHdJaWFzRjB2dXo0d2…

Google News Fri, 23 Jan 2026

Shares of CSG, one of the world’s fastest-growing defense firms, jump 31% on debut - CNBC

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxQX1NTY01SMkk1SDBQel9HNUFtcTRCQ0l6anFNVUx2eVA5ZDI0QkNkbnpGUl9iWmV3RnpkaVl5UlI3Z2o4UEhoSzVuM2tiTXNnNEFJcElKbTdiYmZfSEx5bTVyS1JUQ01MbS1kSEpWcmlPVTE5VzhPaVVTRnZYUWJ2ZmtENzRvTE3SAYwBQV…

Google News hu, 16 Apr 2026

Amsterdam-Rotterdam-Antwerp Oil Product Stocks Drop to 12-Year Low - Marine News Magazine

<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxPSjd3UnZzR1Y1VW1PVHYteEhPTV9XX2RxYkVKUjZzcnFlOE9jVDBjT2hoaVFuVjhnOHBIdkJ3UDBtUFY1WWVJXzkyLWttVFNOaHJJaHI0SkhOWTcxbWlHSG1jWHdOWUsyMGtzUy1VQjVrZnBGYTEtM3NldEI0WmhHdFh3?oc=5" target=…

ASTERDM — Frequently Asked Questions

What is the current share price of Aster DM Quality Care Limited (ASTERDM)?

As of 2026-07-16 05:21 IST, Aster DM Quality Care Limited (ASTERDM) trades at ₹814.00 on NSE. Its 52-week range is ₹535.60 to ₹814.95.

What is the market capitalisation of ASTERDM?

Aster DM Quality Care Limited (ASTERDM) has a market capitalisation of ₹42,175.05 Cr on NSE.

What is the P/E ratio of ASTERDM?

ASTERDM trades at a trailing price-to-earnings (P/E) ratio of 7.55. The industry average P/E is 39.70. Its price-to-book (P/B) ratio is 9.18.

Does ASTERDM pay a dividend?

Aster DM Quality Care Limited (ASTERDM) currently offers a dividend yield of 0.49%.

What is the return on equity (ROE) of ASTERDM?

ASTERDM has a return on equity (ROE) of 8.48%. Its return on capital employed (ROCE) is 9.71%.

Is ASTERDM a good stock to buy?

This page provides a data-driven analysis of Aster DM Quality Care Limited (ASTERDM), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space